Globus Medical (GMED) Sees Sequential Revenue Surge, Citizens JMP Maintains Market Perform Rating
Globus Medical Inc. (NYSE:GMED) ranks among the best mid-cap stocks with huge upside potential. Following the publication of Globus Medical Inc.
Globus Medical Inc (GMED)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Paradice Investment Management David Paradice | 663,038 | $37,972,186 | +21% | 8.52% |
| 2. | Bayforest Capital Theodoros Tsagaris | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $53.88 | 615 | $33,136.20 | 2,005 | 2020-08-24 | Filing | |
| $47.75 | 690 | $32,947.50 | 1,390 | 2020-07-22 | Filing | |
| $48.20 | 700 | $33,740.00 | 700 | 2020-06-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $58.46 | 10,000 | $584,600.00 | 25,384 | 2025-09-15 | Filing | |
| $78.68 | 7,500 | $590,100.00 | 35,384 | 2025-02-28 | Filing | |
| $89.17 | 1,666 | $148,557.22 | 0 | 2025-01-10 | Filing | |
| $88.17 | 12,501 | $1,102,213.17 | 1,666 | 2025-01-10 | Filing | |
| $87.00 | 2,500 | $217,501.50 | 0 | 2024-12-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,185,461 | $67,891,352 | 0.5% | |
| 2. | 679,075 | $38,890,625 | 0.04% | |
| 3. | 476,531 | $27,953,309 | 0.04% | |
| 4. | 446,413 | $25,566,073 | 0.14% | |
| 5. | 279,335 | $15,997,515 | 1.14% |
News See All
12 Best Mid-Cap Stocks with Huge Upside Potential
The Commerce Department said on August 29 that core inflation, which does not include food and energy expenses, stood at a 2.9% seasonally adjusted annual rate based on the personal consumption expenditures...
Globus Medical, Inc. (NYSE:GMED) Q2 2025 Earnings Call Transcript
Operator: Welcome to Globus Medical's Second Quarter 2025 Earnings Call. [Operator Instructions].
Canaccord Downgrades Globus Medical (GMED) PT to $90, Maintains Buy Rating
Globus Medical Inc. (NYSE:GMED) is one of the most undervalued stocks to buy and hold for 3 years.
Globus Medical Introduces DuraPro with Navigation to Enhance Surgical Workflows, Safety
Globus Medical Inc. (NYSE:GMED) is one of the best mid cap pharma stocks to buy. On July 15, Globus Medical announced the introduction of DuraPro with Navigation.
10 Most Undervalued Stocks to Buy and Hold for 3 Years
On July 17, Lori Calvasina, RBC Capital Markets head of US equity strategy, joined 'Closing Bell' on CNBC to discuss whether the market is fully valued at present levels.
10 Best Mid Cap Pharma Stocks to Buy
On July 14, Emily Field, the head of European pharma research at Barclays, appeared on CNBC to discuss which drug makers would be most impacted by 30% US tariffs on EU imports.
Piper Sandler Maintained a Buy Rating on Globus Medical (GMED), Kept the PT Unchanged
Globus Medical, Inc. (NYSE:GMED) is one of the Best 52-Week Low Stocks to Buy According to Analysts. On July 3, Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Globus Medical, Inc.
12 Best 52-Week Low Stocks to Buy According to Analysts
On July 15, the Consumer Price Index data revealed that core inflation increased by 0.2% on the month; however, the annual rate of 2.9% remains within the estimated range.
Globus Medical (GMED) Fell 19% in Q2
Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center Billionaire Hedge Funds
